 ️ Insiders Are Betting Big: Who Invested $100M+ in One Day Yesterday's purchases by top managers and funds are not just numbers—they are signals. I've broken down the top 10 insider trades for May 11. Genedx Holdings (WGS) — $46.8M Director Keith Meister bought an additional 1.2 million shares at $38.84, increasing his stake by 34%. Genetic testing is a sector that insiders see as growing, despite the current price. Odyssey Therapeutics (ODTX) — $30M total Two insiders simultaneously: director Li Nan bought $20M (+50% to his stake), and fund Sr One Capital added another $10M. Biotech with clear faith in the pipeline. Pulse Biosciences (PLSE) — $13M Robert Duggan (known for successful biotech bets) bought 660k shares. His past trades have yielded 10x returns. What else stands out: • Atara Biotherapeutics (ATRA) — Ecor1 Capital bought $4.7M at $9.35. The fund's stake grew by 49%. • Alphatec Holdings (ATEC) — director Keith Valentine bought $996k at $7.38, increasing his stake by 139%. Maximum confidence. • Starlink Ai Acquisition Corp (OTAI) — purchase of $2.2M at $10. AI-SPAC, insiders voting with their wallets. Market context: 2026 marks the transition from passive AI to autonomous agents. Google launches Gemini Enterprise, and the A2A (Agent-to-Agent) protocol becomes the standard. Competition is now not about model size, but about agents' ability to actually get things done. Conclusion: Insiders are entering biotech and genomics with large sums. The AI sector is moving into a phase of practical application. I'm watching WGS and ODTX as the strongest signals. Data: OpenInsider, 11.05.2026